- BNF:
- 5.3.5
- Status:
- Red
- Decision Date:
- December 2013
Comments
RED:1,3 NICE TA300: as an option for treating chronic hepatitis C in children and young people
NHS England drug. To be used in line with NHS England commissioning intentions
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again